Serial Number: 78729275

Word Mark: T

Goods and Services: (ABANDONED) IC 005. US 006 018 044 046 051 052. G & S: Housemark for pharmaceutical components; pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular diseases, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular diseases, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; and anti-cancer vaccines

Mark Drawing Code: (3) DESIGN PLUS WORDS, LETTERS, AND/OR NUMBERS

Design Search Code: 26.01.21 - Circles that are totally or partially shaded.
26.05.21 - Triangles that are completely or partially shaded
26.09.02 - Plain single line squares; Squares, plain single line
27.01.04 - Letters forming objects; Numbers forming objects; Objects composed of letters or numerals; Punctuation forming objects

Filing Date: 10/07/2005

Current Basis: 1B

Original Filing Basis: 1B

Owner: (APPLICANT) Titan Pharmaceuticals Inc. CORPORATION DELAWARE Suite 505 400 Oyster Point Boulevard South San Francisco CALIFORNIA 94080

Attorney of Record: Rosemary S. Tarlton

Description of Mark: The mark consists of the letter T with a triangle logo.

Type of Mark: TRADEMARK

Register: PRINCIPAL

Live/Dead Indicator: DEAD

SiteNo: 8315